Resolvin D1 drives establishment of Leishmania amazonensis infection

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Malta Santos, Hayna ^a,b   Andrade, Bruno B ^a,c   Zanette, Dalila L ^a   Costa, Jackson M ^a   Bozza, Patrícia T ^a   Bandeira Melo, Christianne ^d   Barral, Aldina ^a,b   Francą Costa, Jaqueline ^a,b   Borges, Valéria M ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Fundacao Jose Silveira   (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DOCOSAHEXAENOIC ACID; RESOLVIN D1;

ADOLESCENT; ADULT; BLOOD; CHILD; FEMALE; HUMAN; LEISHMANIA; LEISHMANIASIS; MACROPHAGE; MALE; METABOLISM; MIDDLE AGED; PARASITOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; CHILD; DOCOSAHEXAENOIC ACIDS; FEMALE; HUMANS; LEISHMANIA; LEISHMANIASIS; MACROPHAGES; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 85017353141     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep46363     Document Type: Article

References (33)

1. Serhan, C. N., Chiang, N., Dalli, J. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution. Semin Immunol 27, 200-215, doi: 10. 1016/j.smim.2015.03.004 (2015).
2. Wang, L., et al. Effects of resolvin D1 on inflammatory responses and oxidative stress of lipopolysaccharide-induced acute lung injury in mice. Chin Med J (Engl) 127, 803-809 (2014).
3. Titos, E., et al. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J Immunol 187, 5408-5418, doi: 10. 4049/jimmunol. 1100225 (2011).
4. Franca-Costa, J., et al. Differential Expression of the Eicosanoid Pathway in Patients With Localized or Mucosal Cutaneous Leishmaniasis. J Infect Dis 213, 1143-1147, doi: 10. 1093/infdis/jiv548 (2016).
5. Scott, P., Novais, F. O. Cutaneous leishmaniasis: Immune responses in protection and pathogenesis. Nat Rev Immunol 16, 581-592, doi: 10. 1038/nri.2016. 72 (2016).
6. Costa, J. M., et al. Spontaneous regional healing of extensive skin lesions in diffuse cutaneous Leishmaniasis (DCL). Rev Soc Bras Med Trop 28, 45-47 (1995).
7. Franca-Costa, J., et al. Arginase I, polyamine, and prostaglandin E2 pathways suppress the inflammatory response and contribute to diffuse cutaneous leishmaniasis. J Infect Dis 211, 426-435, doi: 10. 1093/infdis/jiu455 (2015).
8. Barral-Netto, M., et al. Transforming growth factor-beta in leishmanial infection: A parasite escape mechanism. Science 257, 545-548 (1992).
9. Lacerda, D. I., et al. Kinetoplastid membrane protein-11 exacerbates infection with Leishmania amazonensis in murine macrophages. Mem Inst Oswaldo Cruz 107, 238-245 (2012).
10. Sacks, D., Sher, A. Evasion of innate immunity by parasitic protozoa. Nat Immunol 3, 1041-1047, doi: 10. 1038/ni1102-1041 (2002).
11. Luz, N. F., et al. Heme oxygenase-1 promotes the persistence of Leishmania chagasi infection. J Immunol 188, 4460-4467, doi: 10. 4049/jimmunol. 1103072 (2012).
12. Afonso, L., et al. Interactions with apoptotic but not with necrotic neutrophils increase parasite burden in human macrophages infected with Leishmania amazonensis. J Leukoc Biol 84, 389-396, doi: 10. 1189/jlb.0108018 (2008).
13. Mougneau, E., Bihl, F., Glaichenhaus, N. Cell biology and immunology of Leishmania. Immunol Rev 240, 286-296, doi: 10. 1111/j.1600-065X.2010.00983. x (2011).
14. Barral, A., et al. Transforming growth factor-beta in human cutaneous leishmaniasis. Am J Pathol 147, 947-954 (1995).
15. Khouri, R., et al. IFN-beta impairs superoxide-dependent parasite killing in human macrophages: Evidence for a deleterious role of SOD1 in cutaneous leishmaniasis. J Immunol 182, 2525-2531, doi: 10. 4049/jimmunol.0802860 (2009).
16. Hsieh, C. J., et al. Baicalein inhibits IL-1beta-A nd TNF-alpha-induced inflammatory cytokine production from human mast cells via regulation of the NF-kappaB pathway. Clin Mol Allergy 5, 5, doi: 10. 1186/1476-7961-5-5 (2007).
17. Xu, J., et al. Inhibition of 12/15-lipoxygenase by baicalein induces microglia PPARbeta/delta: A potential therapeutic role for CNS autoimmune disease. Cell Death Dis 4, e569, doi: 10. 1038/cddis.2013. 86 (2013).
18. Spite, M., Claria, J., Serhan, C. N. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab 19, 21-36, doi: 10. 1016/j.cmet.2013. 10.006 (2014).
19. Wang, B., et al. Resolvin D1 protects mice from LPS-induced acute lung injury. Pulm Pharmacol Ther 24, 434-441, doi: 10. 1016/j.pupt.2011.04.001 (2011).
20. Akuffo, H. O., Fehniger, T. E., Britton, S. Differential recognition of Leishmania aethiopica antigens by lymphocytes from patients with local and diffuse cutaneous leishmaniasis. Evidence for antigen-induced immune suppression. J Immunol 141, 2461-2466 (1988).
21. Silveira, F. T., Lainson, R., Corbett, C. E. Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: A review. Mem Inst Oswaldo Cruz 99, 239-251, doi:/S0074-02762004000300001 (2004).
22. Fredman, G., Serhan, C. N. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochem J 437, 185-197, doi: 10. 1042/BJ20110327 (2011).
23. Probst, C. M., et al. A comparison of two distinct murine macrophage gene expression profiles in response to Leishmania amazonensis infection. BMC Microbiol 12, 22, doi: 10. 1186/1471-2180-12-22 (2012).
24. Luo, B., et al. Resolvin D1 Programs Inflammation Resolution by Increasing TGF-beta Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis. J Neurosci 36, 9590-9603, doi: 10. 1523/JNEUROSCI.0020-16.2016 (2016).
25. Maloney, J. P., Narasimhan, J., Biller, J. Decreased TGF-beta1 and VEGF Release in Cystic Fibrosis Platelets: Further Evidence for Platelet Defects in Cystic Fibrosis. Lung 194, 791-798, doi: 10. 1007/s00408-016-9925-9 (2016).
26. Savill, J., Fadok, V. Corpse clearance defines the meaning of cell death. Nature 407, 784-788, doi: 10. 1038/35037722 (2000).
27. Chiang, N., et al. Inhaled carbon monoxide accelerates resolution of inflammation via unique proresolving mediator-heme oxygenase-1 circuits. J Immunol 190, 6378-6388, doi: 10. 4049/jimmunol. 1202969 (2013).
28. Magez, S., et al. Tumor necrosis factor (TNF) receptor-1 (TNFp55) signal transduction and macrophage-derived soluble TNF are crucial for nitric oxide-mediated Trypanosoma congolense parasite killing. J Infect Dis 196, 954-962, doi: 10. 1086/520815 (2007).
29. Daulouede, S., et al. Human macrophage tumor necrosis factor (TNF)-alpha production induced by Trypanosoma brucei gambiense and the role of TNF-alpha in parasite control. J Infect Dis 183, 988-991, doi: 10. 1086/319257 (2001).
30. Ogata, H., et al. Effects of aspirin-triggered resolvin D1 on peripheral blood mononuclear cells from patients with Chagas' heart disease. Eur J Pharmacol 777, 26-32, doi: 10. 1016/j.ejphar.2016.02.058 (2016).
31. Medeiros, A., Peres-Buzalaf, C., Fortino Verdan, F., Serezani, C. H. Prostaglandin E2 and the suppression of phagocyte innate immune responses in different organs. Mediators Inflamm 2012, 327568, doi: 10. 1155/2012/327568 (2012).
32. Araujo-Santos, T., et al. Role of prostaglandin F2alpha production in lipid bodies from Leishmania infantum chagasi: Insights on virulence. J Infect Dis 210, 1951-1961, doi: 10. 1093/infdis/jiu299 (2014).
33. Andrade, B. B., et al. Heme Oxygenase-1 Regulation of Matrix Metalloproteinase-1 Expression Underlies Distinct Disease Profiles in Tuberculosis. J Immunol 195, 2763-2773, doi: 10. 4049/jimmunol. 1500942 (2015).